| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 8,739,350 | 9,149,803 | 9,877,429 | 9,730,205 | | Cost of Revenue | 7,102,274 | 7,399,690 | 7,990,873 | 7,828,791 | | | Gross Profit | 1,637,076 | 1,750,113 | 1,886,556 | 1,901,414 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,231,753 | 1,328,249 | 1,381,804 | 1,342,754 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 405,323 | 421,864 | 504,752 | 558,660 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,514 | 5,223 | 2,813 | 4,270 | | Earnings Before Interest And Taxes | 408,837 | 427,087 | 507,565 | 562,930 | | Interest Expense | 28,233 | 28,400 | 26,410 | 27,511 | | Income Before Tax | 380,604 | 398,687 | 481,155 | 535,419 | | Income Tax Expense | 154,438 | 161,033 | 204,341 | 201,306 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 226,166 | 237,654 | 276,814 | 334,113 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 226,166 | 237,654 | 276,814 | 334,113 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $226,166 | $237,654 | $276,814 | $334,113 |
|
0.45% Nasdaq 
0.20%
Income Statement
